Root Financial Partners
HAE icon

Root Financial Partners’s Haemonetics HAE Stock Holding History

Root Financial Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.8K Buy
+378
New +$35.2K ﹤0.01% 1200
2026
Q2 		– Sell
-105
Closed -$5.92K – 1581
2026
Q1 		$5.92K Buy
105
+7
+7% +$456 ﹤0.01% 1887
2025
Q4 		$7.86K Buy
98
+81
+476% +$5.44K ﹤0.01% 1604
2025
Q3 		$829 Buy
+17
New +$1.05K ﹤0.01% 2088

Other funds holding HAE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
River Road Asset Management
River Road Asset Management Louisville, Kentucky $8.42B AUM 5.65% 1-Year Est. Return

Root Financial Partners's HAE Position: Q3 2026 in Review

Root Financial Partners opened a new position in Haemonetics (HAE) in Q3 2026: 378 shares worth $39.8K. The stake represents ﹤0.01% of the portfolio and ranks #1200 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in HAE as recently as Q1 2026.

Root Financial Partners first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Root Financial Partners held 378 shares of Haemonetics worth $39.8K as of Q3 2026.
  • Haemonetics was a new Root Financial Partners position in Q3 2026.
  • Haemonetics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1200 holding.
  • Root Financial Partners first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.